Clinical Trials Directory

Trials / Completed

CompletedNCT01276743

Study of PTPN22 C1858T Polymorphism in Children and Adolescents of Greek Origin With T1DM

Study of Protein Tyrosine Phosphatase Non-receptor Type 22 (PTPN22) C1858T Polymorphism in Children and Adolescents of Greek Origin With Type 1 Diabetes Mellitus (T1DM)

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
3 Years – 18 Years
Healthy volunteers
Accepted

Summary

The protein tyrosine phosphatase non-receptor type 22 (PTPN22) gene encodes a lymphoid-specific phosphatase (LYP) which is an important downregulatory factor of T cell activation. A PTPN22 polymorphism, C1858T, was found associated with T1DM in different Caucasian populations. In this observational case-control study, we aimed at confirming the role of PTPN22, C1858T polymorphism in T1DM predisposition in a Greek population.

Conditions

Timeline

Start date
2010-02-01
Primary completion
2011-07-01
Completion
2013-02-01
First posted
2011-01-13
Last updated
2014-02-28

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01276743. Inclusion in this directory is not an endorsement.